drugset / Trial / NCT07662525

Atorvastatin Combined With NAC Plus Romiplostim for Management of ITP

NCT07662525

Not yet recruiting 50 enrolled Peking University People's Hospital
NaSingle-groupOpen-labelTreatment

Summary

This is a prospective, single-arm, open-lable, single-center study and we aimed to determine whether atorvastatin combined with N-acetyl-L-cysteine (NAC) plus romiplostim could induce sustained response off-treatment (SRoT) in adult patients with ITP following CS failure.

Timeline

Start
2026-06-01
Primary completion
2027-12-30
Completion
2028-12-30

Drugs

EvaluationDrugModalityDoseRoute
Subject Atorvastatin Small molecule 20 mg
Subject N-acetylcysteine Small molecule 400 mg
Subject Romiplostim Peptide 3 ug/kg